Healthcare Equipment and Supplies
Company Overview of IlluminOss Medical, Inc.
IlluminOss Medical, Inc., a medical device company, develops minimally invasive orthopedic systems for the stabilization and treatment of bone fractures. Its IlluminOss Photodynamic Bone Stabilization System utilizes a photodynamic (light-curable) polymer system to eliminate the need for traditional methods of bone fixation with external pins, plates, and screws. The company’s IlluminOss Photodynamic Bone Stabilization System has applications in low load bearing bones in the metacarpal, radius, ulna, distal radius, olecranon, clavicle, and fibula. IlluminOss Medical was founded in 2007 and is based in East Providence, Rhode Island.
993 Waterman Avenue
East Providence, RI 02914
Founded in 2007
Key Executives for IlluminOss Medical, Inc.
Founder, Chief Executive Officer, President and Chief Technology Officer
Vice President of Finance
Vice President of Regulatory and Clinical Affairs
Compensation as of Fiscal Year 2015.
IlluminOss Medical, Inc. Key Developments
IlluminOss Medical, Inc. Appoints Clive V. Ridgwell as Vice President of Sales
Jul 24 15
IlluminOss Medical, Inc. has appointed Clive V. Ridgwell as vice president of sales. The company announced that Ridgwell brings more than 30 years of commercial experience in medical device fields which he will apply to the further development of IlluminOss' product strategy in global markets. Ridgwell joins IlluminOss from Zimmer Inc., where he spent the last 21 years working in a number of senior executive roles within its European, Middle Eastern and African operations. Most recently, he served as vice president of the Trauma Division. Prior to that, he held the positions of vice president for the Spine Division and managing director and general manager of Zimmer UK, Nordic, Scandinavia and Southern Africa.
IlluminOss Medical Announces Conditional FDA Approval for Clinical Trials of Groundbreaking Photodynamic Bone Stabilization System in US
Nov 18 14
IlluminOss Medical announced that it has received conditional approval from the FDA to conduct a clinical trial for the treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. IlluminOss expects to begin enrolling clinical sites and initiate the trial shortly. IlluminOss' Photodynamic Bone Stabilization System (PBSS) is the world's first and only system of its kind and offers significant advantages for the treatment of complex fractures. It is commercially available in international markets and has been in clinical use since 2010. IlluminOss' novel approach has proven successful in its widespread use in Europe, where PBSS has been used in the treatment of over 700 patients. Benefits observed from the use of the product in patients include smaller incisions, shorter procedure times, and more rapid post-procedure patient mobility with reduced hospital stays and lower complication rates. The minimally invasive procedure incorporates the use of a thin walled PET balloon that is infused with a liquid monomer and inserted into the intramedullary canal of the bone conforming to the shape of the patient's specific bone. The device forms as an implant once the surgeon activates the visible light delivered within the PET balloon. Once cured, the implant provides longitudinal strength and rotational stability over the length of the implant.
IlluminOss Medical, Inc. Presents at Boston CEO Conference, Jun-04-2014 01:45 PM
Jun 2 14
IlluminOss Medical, Inc. Presents at Boston CEO Conference, Jun-04-2014 01:45 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Dirk M. Kuyper, Chief Executive Officer and President.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|